Author

Mariano Monzó

Observed names: M MONZO, M Monzo, M Monzó, M. Monzo, M. Monzo-Planella, M. Monzó, Mariano Monzo, Mariano Monzo Md, Mariano Monzo Planella, Mariano Monzoó, Mariano Monzó, Mariano Monzó Planella, Mariano Monzó-Planella, Monzo, M., Monzo, Mariano, Monzó, Mariano

Institutions: Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona

Observed institutions: Universitat Autònoma de Barcelona, The University of Texas MD Anderson Cancer Center, Hospital de Sant Pau, Institut Català d'Oncologia, Hospital Clínic de Barcelona, Department of Embryology, Hospital Arnau de Vilanova, Hospital General de Catalunya, Hospital General Yagüe, Institut d'Investigacions Biomèdiques de Barcelona, Vall d'Hebron Hospital Universitari, Hospital Del Mar, Clinica Universidad de Navarra, Hospital Clínico Universitario Lozano Blesa, Hospital Universitari Joan XXIII de Tarragona, Banc de Sang i Teixits, Hospital Municipal de Badalona, Hospital Universitari Germans Trias i Pujol, Hospital Universitari de Girona Doctor Josep Trueta, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigación Médica Aplicada, Universidad Autónoma de Madrid, Universitat de Barcelona

ORCID: 0000-0003-2322-4851

Observed ORCID: 0000-0003-2322-4851

OpenAlex ID: A5035019205

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

2006 · E Bandrés, E Cubedo, et al. · Molecular Cancer · 796

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

2013 · Xavier Bosch, Montserrat Rovira, et al. · Journal of the American College of Cardiology · 632

A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers

1999 · Mariano Monzó, Rafael Rosell, et al. · Journal of Clinical Oncology · 487

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer

2009 · Elena Gallardo, Alfons Navarro, et al. · Carcinogenesis · 343

Paclitaxel Resistance in Non–Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations

1999 · Mariano Monzó, Rafael Rosell, et al. · Journal of Clinical Oncology · 307

PintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2

2013 · Oskar Marín-Béjar, Francesco P Marchese, et al. · Genome biology · 265

Overlapping expression of microRNAs in human embryonic colon and colorectal cancer

2008 · Mariano Monzo, Alfons Navarro, et al. · Cell Research · 184

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma

2009 · Alfons Navarro, Tania Diaz, et al. · Blood · 170

MicroRNA expression profiling in classic Hodgkin lymphoma

2007 · Alfons Navarro, Anna Gaya, et al. · Blood · 170

Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.

2001 · M Sanchez-Cespedes, S A Ahrendt, et al. · PubMed · 169

Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer

1998 · Eva Martínez-López, Albert Abad, et al. · Gastroenterology · 148

Epigenetic regulation mechanisms of microRNA expression

2017 · Sara Morales, Mariano Monzo, et al. · BioMolecular Concepts · 144

miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma

2014 · Rut Tejero, Alfons Navarro, et al. · PLoS ONE · 134

YKT6 expression, exosome release, and survival in non-small cell lung cancer

2016 · Marc Ruiz-Martinez, Alfons Navarro, et al. · Oncotarget · 129

A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast Carcinoma

2008 · Ramon Colomer, Mariano Monzo, et al. · Clinical Cancer Research · 123

The lincRNAHOTAIRM1, located in theHOXAgenomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

2015 · Marina Díaz-Beyá, the Cooperative AML group CETLAM, et al. · Oncotarget · 110

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients

1998 · M. Sánchez-Céspedes, M. Monzó, et al. · Annals of Oncology · 93

Hematopoiesis-related microRNA expression in myelodysplastic syndromes

2009 · Aina Pons, Benet Nomdedeu, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 91

LincRNA-p21 Impacts Prognosis in Resected Non–Small Cell Lung Cancer Patients through Angiogenesis Regulation

2016 · Joan J. Castellano, Alfons Navarro, et al. · Journal of Thoracic Oncology · 89

Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer

2006 · Joan Carles, Mariano Monzo, et al. · International Journal of Radiation Oncology*Biology*Physics · 89

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer

2012 · Marc Campayo, Alfons Navarro, et al. · European Respiratory Journal · 80

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis

2011 · Tania Diaz, Alfons Navarro, et al. · PLoS ONE · 76

Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients

2009 · R. Artells, I. Moreno, et al. · European Journal of Cancer · 71

Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients

2009 · Juan josé Grau, Miguel Caballero, et al. · Acta Oto-Laryngologica · 70

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

2006 · Mariano Monzo, Salut Brunet, et al. · Blood · 69

Works count: 251

Citation count: 7,663

H-index: 46

I10-index: 101